Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway
European Cytokine Network · 2019
DOI: 10.1684/ecn.2019.0431 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Cytokine Network, 2019. Verfasst von Yuan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia (Clinical Research Center for Anesthesiology of ERAS in Hunan Province), Hunan provincial people's hospital (First Affiliate…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia (Clinical Research Center for Anesthesiology of ERAS in Hunan Province), Hunan provincial people's hospital (First Affiliated Hospital of Hunan Normal University), Changsha 410005, P.R.China.
Zitieren
APA
Zhao, Y., Kong, G. Y., Pei, W. M., Zhou, B., Zhang, Q. Q., & Pan, B. B. (2019). Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway. European Cytokine Network. https://doi.org/10.1684/ecn.2019.0431
Vancouver
Zhao Y, Kong GY, Pei WM, Zhou B, Zhang QQ, Pan BB. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway. European Cytokine Network. 2019. doi:10.1684/ecn.2019.0431
BibTeX
@article{Zhao2019,
author = {Zhao, Yuan and Kong, Gao-Yin and Pei, Wan-Min and Zhou, Bo and Zhang, Qin-Qin and Pan, Bing-Bing},
title = {Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway},
journal = {European Cytokine Network},
year = {2019},
doi = {10.1684/ecn.2019.0431}
}
EUVIMED